Maeng, D., Li, Y., Lawrence, M., Keane, S., Cross, W., Conner, K. R., & Lee, H. B. (2022). Impact of mandatory COVID‐19 shelter‐in‐place order on controlled substance use among rural versus urban communities in the United States. The Journal of Rural Health, Prépublication, jrh.12688.
Al-Imam, A., Motyka, M. A., Witulska, Z., Younus, M., & Michalak, M. (2022). Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland. International Journal of Environmental Research and Public Health, 19(11), 6619.
Feinberg, M. E., Fang, S., Fosco, G. M., Sloan, C. J., Mogle, J., & Spoth, R. L. (2022). Long-term Effects of Adolescent Substance Use Prevention on Participants, Partners, and their Children: Resiliency and Outcomes 15 Years Later During the COVID-19 Pandemic. Prevention Science, Prépublication.
Brailovskaia, J., & Margraf, J. (2022). Addictive social media use during Covid-19 outbreak: Validation of the Bergen Social Media Addiction Scale (BSMAS) and investigation of protective factors in nine countries. Current Psychology, Prépublication.
Lui, B., White, R. S., Aaronson, J., & Hoyler, M. (2022). Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA. Journal of Comparative Effectiveness Research, 11(9), 643–648.
Joyce, K. M., Cameron, E. E., Sulymka, J., Protudjer, J. L. P., & Roos, L. E. (2022). Changes in Maternal Substance Use During the COVID-19 Pandemic. Journal of Studies on Alcohol and Drugs, 83(3), 352–357.
Parks, M. J., Fleischer, N. L., & Patrick, M. E. (2022). Increased nicotine vaping due to the COVID-19 pandemic among US young adults: Associations with nicotine dependence, vaping frequency, and reasons for use. Preventive Medicine, 159, 107059.
Centre canadien sur les dépendances et l’usage de substances, & Commission de la santé mentale du Canada. (2022). Santé mentale et usage de substances pendant la pandémie de COVID-19 : rapport sommaire 5 : les idées suicidaires et l’usage de substances. CCDUS, CSMC.
Estévez-Danta, A., Bijlsma, L., Capela, R., Cela, R., Celma, A., Hernández, F., Lertxundi, U., Matias, J., Montes, R., Orive, G., Prieto, A., Santos, M. M., Rodil, R., & Quintana, J. B. (2022). Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology. Science of The Total Environment, Prépublication, 155697.
Freibott, C. E., Stein, M. D., & Lipson, S. K. (2022). The influence of race, sexual orientation and gender identity on mental health, substance use, and academic persistence during the COVID-19 pandemic: A cross-sectional study from a national sample of college students in the Healthy Minds Study. Drug and Alcohol Dependence Reports, Prépublication, 100060.
Ling, P. M., Crosbie, E., Holmes, L. M., Hoang, C., & Hoeper, S. (2022). Cannabis dispensary online marketing practices in response to COVID-19 lockdowns. Substance Abuse, 43(1), 1116–1119.
Maguire-Jack, K., Steinman, K. J., Lesnick, J., Solomon, A., West, K., Roush, K., Zimpfer, K., & Cunningham, N. (2022). Implementing Triple P during the COVID-19 pandemic with families at risk for substance use. Child Abuse & Neglect, 129, 105636.
Koós, M., Demetrovics, Z., Griffiths, M. D., & Bőthe, B. (2022). No Significant Changes in Addictive and Problematic Behaviors During the COVID-19 Pandemic and Related Lockdowns: A Three-Wave Longitudinal Study. Frontiers in Psychology, 13.
Yeager, S., Abramovitz, D., Harvey-Vera, A. Y., Vera, C. F., Algarin, A. B., Smith, L. R., Rangel, G., Artamonova, I., Patterson, T. L., Bazzi, A. R., Brugman, E. L., & Strathdee, S. A. (2022). A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk. BMC Public Health, 22(1), 842.
Reilly, E. D., Chamberlin, E. S., Duarte, B. A., Harris, J. I., Shirk, S. D., & Kelly, M. M. (2022). The Impact of COVID-19 on Self-Reported Substance Use, Well-Being, and Functioning Among United States Veterans: A Cross-Sectional Study. Frontiers in Psychology, 13.
Ross, J. A., Malone, P. K., & Levy, S. (2022). The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US. Clinical Infectious Diseases, Prépublication, ciac311.
Shapira, B., & Rosca, P. (2022). Transformation of substance use disorder treatment services during COVID-19 - A lasting change? Journal of Substance Use, Prépublication, 1–8.
McAdam, E., Hayashi, K., Dong, H., Cui, Z., Sedgemore, K., Dietze, P., Phillips, P., Wilson, D., Milloy, M.-J., & DeBeck, K. (2022). Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada. Drug and Alcohol Dependence, 236, 109471.
Layman, H. M., Thorisdottir, I. E., Halldorsdottir, T., Sigfusdottir, I. D., Allegrante, J. P., & Kristjansson, A. L. (2022). Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review. Current Psychiatry Reports, Prépublication.
Cheng, C., & Lau, Y.-C. (2022). Social Media Addiction during COVID-19-Mandated Physical Distancing: Relatedness Needs as Motives. International Journal of Environmental Research and Public Health, 19(8), 4621.
Minoyan, N., Høj, S. B., Zolopa, C., Vlad, D., Bruneau, J., & Larney, S. (2022). Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada. Harm Reduction Journal, 19(1), 38.
Ceci, F., Di Carlo, F., Burkauskas, J., Salone, A., De Luca, I., Cicconcelli, D., Giorgetti, V., La Fratta, I., Todaro, A., Simonato, P., Martinotti, G., di Giannantonio, M., & Corazza, O. (2022). Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy. International Journal of Mental Health and Addiction, Prépublication.
Walters, S. M., Bolinski, R. S., Almirol, E., Grundy, S., Fletcher, S., Schneider, J., Friedman, S. R., Ouellet, L. J., Ompad, D. C., Jenkins, W., & Pho, M. T. (2022). Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis. Addiction Science & Clinical Practice, 17(1), 24.
Wessely, S., Tappiser, M., Eisenburger, N., Feddern, S., Gehlhar, A., Kilimann, A., Klee, L., Niessen, J., Schmidt, N., Wiesmüller, G. A., Kossow, A., Grüne, B., & Joisten, C. (2022). Changes in alcohol consumption, eating behaviors, and body weight during quarantine measures: Analysis of the CoCo-Fakt study. Obesity Facts, Prépublication.
Brothers, T. D., Leaman, M., Bonn, M., Lewer, D., Atkinson, J., Fraser, J., Gillis, A., Gniewek, M., Hawker, L., Hayman, H., Jorna, P., Martell, D., O’Donnell, T., Rivers-Bowerman, H., & Genge, L. (2022). Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. Drug and Alcohol Dependence, Prépublication, 109440.
Moniri, R., Pahlevani Nezhad, K., & Lavasani, F. F. (2022). Investigating Anxiety and Fear of COVID-19 as Predictors of Internet Addiction With the Mediating Role of Self-Compassion and Cognitive Emotion Regulation. Frontiers in Psychiatry, 13.
Tholen, R., Ponnet, K., Van Hal, G., De Bruyn, S., Buffel, V., Van de Velde, S., Bracke, P., & Wouters, E. (2022). Substance Use among Belgian Higher Education Students before and during the First Wave of the COVID-19 Pandemic. International Journal of Environmental Research and Public Health, 19(7), 4348.
Boogaerts, T., Quireyns, M., De prins, M., Pussig, B., De Loof, H., Matheï, C., Aertgeerts, B., Van Coppenolle, V., Fransen, E., Covaci, A., & van Nuijs, A. L. N. (2022). Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater. International Journal of Drug Policy, Publication, 103679.
Dumas, T. M., Ellis, W. E., Van Hedger, S., Litt, D. M., & MacDonald, M. (2022). Lockdown, bottoms up? Changes in adolescent substance use across the COVID-19 pandemic. Addictive Behaviors, 131, 107326.
Moya-Salazar, J., Nuñez, E., Jaime-Quispe, A., Zuñiga, N., Loaiza-Barboza, I. L., Balabarca, E. A., Chicoma-Flores, K., Cañari, B., & Contreras-Pulache, H. (2022). Substance Use in Healthcare Professionals During the COVID-19 Pandemic in Latin America: A Systematic Review and a Call for Reports. Substance Abuse: Research and Treatment, 16, 11782218221085592.
Ostinelli, E. G., Smith, K., Zangani, C., Ostacher, M. J., Lingford-Hughes, A. R., Hong, J. S. W., Macdonald, O., & Cipriani, A. (2022). COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services. BMC Psychiatry, 22(1), 228.
Brener, N. D. (2022). Use of Tobacco Products, Alcohol, and Other Substances Among High School Students During the COVID-19 Pandemic — Adolescent Behaviors and Experiences Survey, United States, January–June 2021. MMWR Supplements, 71.
Nguyen, N., Keyhani, S., Ling, P. M., Hoggatt, K. J., Hasin, D., & Cohen, B. E. (2022). Self-reported Changes in Cannabis Use Due to the COVID-19 Pandemic among US Adults. Journal of Psychoactive Drugs, Prépublication.
Maraz, A., & Yi, S. (2022). Compulsive buying gradually increased during the first six months of the Covid-19 outbreak. Journal of Behavioral Addictions, 11(1), 88–101.
Pavarin, R. M., Fabbri, C., & De Ronchi, D. (2022). COVID-19 hospitalization rates in individuals with substance or alcohol use disorders. Psychiatry Research, 311, 114521.
Daigre, C., Grau-López, L., Palma-Alvarez, R. F., Perea-Ortueta, M., Sorribes-Puertas, M., Serrano-Pérez, P., Quesada, M., Segura, L., Coronado, M., Ramos-Quiroga, J. A., & Colom, J. (2022). A Multicenter Study on the Impact of Gender, Age, and Dual Diagnosis on Substance Consumption and Mental Health Status in Outpatients Treated for Substance Use Disorders During COVID-19 Lockdown. Journal of Dual Diagnosis, Prépublication.
Mallis, N., Dailey, C., Drewry, S., Howard, N., Cordero, J. F., & Welton, M. (2022). SARS-CoV-2 infection and e-cigarette use, binge drinking, and other associated risk factors in a college population. Journal of American College Health, Prépublication.
Freitas, B. H. B. M. de, Gaíva, M. A. M., Diogo, P. M. J., & Bortolini, J. (2022). Relationship between Lifestyle and Self-Reported Smartphone Addiction in adolescents in the COVID-19 pandemic: A mixed-methods study. Journal of Pediatric Nursing, Prépublication.
Tran, D. D., Fitzke, R. E., Wang, J., Davis, J. P., & Pedersen, E. R. (2022). Substance Use, Financial Stress, Employment Disruptions, and Anxiety among Veterans during the COVID-19 Pandemic. Psychological Reports, Prépublication, 003329412210804.
Petrova, M., Miller-Perusse, M., Hirshfield, S., Carrico, A., & Horvath, K. (2021). The Beat Goes On: Stimulant Use and HIV in the Era of COVID-19. JMIR Formative Research, Prépublication.
Pérez, Y. M., Gama, A., Pedro, A. R., de Carvalho, M. J. L., Guerreiro, A. E., Duarte, V., Quintas, J., Aguiar, P., Keygnaert, I., & Dias, S. (2022). The links of stress, substance use and socio-demographic factors with domestic violence during the Covid-19 pandemic in Portugal. Journal of Public Health (Oxford, England), Prépublication, fdac024.
Armstrong, M. J., Cantor, N., Smith, B. T., Jesseman, R., Hobin, E., & Myran, D. T. (2022). Interrupted time series analysis of Canadian legal cannabis sales during the COVID ‐19 pandemic. Drug and Alcohol Review, Prépublication, dar.13465.
Piersanti, V., Consalvo, F., & Marinelli, E. (2022). Substance use disorders during the COVID-19 pandemic: looking for new innovative approaches. Acta Biomedica Atenei Parmensis, 93(1), e2022081–e2022081.
Mezaache, S., Donadille, C., Martin, V., Le Brun Gadelius, M., Appel, L., Spire, B., Briand Madrid, L., Bastien, M., & Roux, P. (2022). Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey. Harm Reduction Journal, 19(1), 26.
Otiashvili, D., Mgebrishvili, T., Beselia, A., Vardanashvili, I., Dumchev, K., Kiriazova, T., & Kirtadze, I. (2022). The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study. Harm Reduction Journal, 19(1), 25.
Schofield, J., Dumbrell, J., Matheson, C., Parkes, T., & Bancroft, A. (2022). The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study. BMC Public Health, 22(1), 500.
Caponnetto, P., Maglia, M., Prezzavento, G. C., & Pirrone, C. (2022). Sexual Addiction, Hypersexual Behavior and Relative Psychological Dynamics during the Period of Social Distancing and Stay-at-Home Policies Due to COVID-19. International Journal of Environmental Research and Public Health, 19(5), 2704.
Chacon, N. C., Walia, N., Allen, A., Sciancalepore, A., Tiong, J., Quick, R., Mada, S., Diaz, M. A., & Rodriguez, I. (2021). Substance use during COVID-19 pandemic: impact on the underserved communities. Discoveries, 9, e141.
Trucco, E. M., Fallah-Sohy, N., Hartmann, S. A., Cristello, J. V., Comer, J. S., & Sutherland, M. T. (2022). The Impact of COVID-19 Experiences on Adolescent Internalizing Problems and Substance Use Among a Predominantly Latinx Sample. Journal of Youth and Adolescence, Prépublication.
Pereira, C. F., Vargas, D. de, Toneloto, F. L., Ito, V. D., & Volpato, R. J. (2022). Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Revista Brasileira de Enfermagem, 75.